Association of the atherogenic index of plasma with cardiovascular risk beyond the traditional risk factors: a nationwide population-based cohort study

Si Hyoung Kim,Yun Kyung Cho,Ye-Jee Kim,Chang Hee Jung,Woo Je Lee,Joong-Yeol Park,Ji Hye Huh,Jun Goo Kang,Seong Jin Lee,Sung-Hee Ihm
DOI: https://doi.org/10.1186/s12933-022-01522-8
IF: 8.949
2022-05-23
Cardiovascular Diabetology
Abstract:The atherogenic index of plasma (AIP) is composed of triglycerides and high-density lipoprotein cholesterol and is a novel marker for assessing the risk of atherogenicity and cardiometabolic health. An association between AIP and greater frequency of major adverse cardiovascular events (MACEs) in patients with type 2 diabetes mellitus and high cardiovascular (CV) disease risk has been reported. However, only few studies have examined the correlation between AIP and CV risk in general populations. We thus aimed to evaluate the relationship between AIP and CV diseases using a large-scale population dataset from the Korean National Health Insurance Service-National Health Screening Cohort (NHIS-HEALS).
cardiac & cardiovascular systems,endocrinology & metabolism
What problem does this paper attempt to address?